Copyright ©2024. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing Cookie Settings ...

Prescient Therapeutics Limited (AU:PTX) has released an update.Don't Miss Our Christmas Offers:Discover the latest stocks recommended by top ...

By studying patient samples and biopsies in the lab, researchers will use advanced technologies to explore how PDAC evolves under treatment, the biological impact of RAS inhibition, and the ...

ASX narrowly avoids disaster after CHESS glitch, with CBA and consumer stocks bouncing back, iron ore slipping.

After a year that saw Ikena Oncology trim back its workforce and pipeline, the oncology biotech thinks it has found a ...

Establishment reflects the clinical progress of IMM-1-104 and its promise in pancreatic cancer - - Follows recent Orphan Drug designation in pancreatic cancer and Fast Track designations in first- and ...

Aberrant activation of the Ras/Raf/MAPK/ERK kinase/extracellular signal-regulated kinase cascade and the VEGF pathway are commonly ... is an oral multikinase inhibitor that inhibits tumor growth ...

Investors have seemingly been taking advantage of pre-Christmas sales, with the ASX 200 closing to the upside by a very ...

Calcitonin gene-related peptide (CGRP) inhibitors are a relatively new type of medication approved by the Food and Drug Administration (FDA) to treat and prevent migraines with or without aura. They ...